Pneumococcal serotypes from acute otitis media in rural Kentucky

Abstract

Depending on rates of efficacy and serotype cross-protection, the current pneumococcal conjugate vaccine could potentially protect against most PNSP strains in all ages, particularly in those < or =24 months.